UNSPSC 51383315: Diclofenac sodium

This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H10Cl2NO2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QTG126297Q, chemically known as 2-((2,6-dichlorophenyl)amino)benzeneacetic acid but more generally known as diclofenac sodium, which bears US NIH Compound Identifier 3033. European Medicines Agency schedules Diclofenac sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01674MIG.

Most nations, for tariff and trade purposes, schedule diclofenac sodium under HS 29224995 and SITC 51465. As of Q4 2014, DICLOFENAC SODIUM remains US FDA's Preferred Term for this commodity. Diclofenac sodium bears US NLM identifiers UMLS ID C0700583 and NCI Concept Code C47984. SMILES: C1CCC(C(C1)CC(=O)[O-])NC2C(CCCC2CL)CL.[NA+].

UNSPSC 51383315 Diclofenac sodium is a Commodity code for a specific nonsteroidal anti-inflammatory drug, but the recent state and local procurement activity tagged under it does not reflect pharmaceutical purchases of diclofenac. The single recent opportunity on record — Seminole County, Florida's IFB60459723LAS — solicits naloxone and drug deactivation systems, which fall outside the scope of diclofenac procurement. The mismatch between the code's nominal scope and the actual work being bought suggests either a classification error in the opportunity record or minimal recent state and local activity for diclofenac sodium itself under this Commodity code.

The Seminole County solicitation, posted June 30, 2026 with a response deadline of July 26, 2023, calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB requires electronic bid submission, includes drug-free workplace and E-Verify compliance, and carries a two-year initial term with an optional one-year renewal. While potentially funded through FEMA, the solicitation does not designate set-asides for disadvantaged enterprises. Without additional recent opportunities under this Commodity code that align with diclofenac procurement, activity appears limited or may indicate that state and local buyers are classifying diclofenac purchases under different UNSPSC codes or procurement vehicles.